These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 7246695

  • 1. Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-alpha metabolite.
    Rosenwaks Z, Jones GS, Henzl MR, Dubin NH, Ghodgaonkar RB, Hoffman S.
    Am J Obstet Gynecol; 1981 Jul 01; 140(5):592-8. PubMed ID: 7246695
    [Abstract] [Full Text] [Related]

  • 2. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY, Fuchs F, Powell AM.
    Obstet Gynecol; 1983 Mar 01; 61(3):285-91. PubMed ID: 6571974
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun 01; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 4. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
    Hanson FW, Izu A, Henzl MR.
    Obstet Gynecol; 1978 Nov 01; 52(5):583-7. PubMed ID: 364357
    [Abstract] [Full Text] [Related]

  • 5. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
    Lundström V.
    Acta Obstet Gynecol Scand; 1978 Nov 01; 57(5):421-8. PubMed ID: 103358
    [Abstract] [Full Text] [Related]

  • 6. Flurbiprofen for the treatment of primary dysmenorrhea.
    Shapiro SS.
    Am J Med; 1986 Mar 24; 80(3A):71-5. PubMed ID: 3457524
    [Abstract] [Full Text] [Related]

  • 7. A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea.
    Mehlisch DR, Fulmer RI.
    J Womens Health; 1997 Feb 24; 6(1):83-92. PubMed ID: 9065377
    [Abstract] [Full Text] [Related]

  • 8. The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.
    Joelsson I, Lalos O.
    Acta Obstet Gynecol Scand Suppl; 1979 Feb 24; 87():45-49. PubMed ID: 380251
    [Abstract] [Full Text] [Related]

  • 9. Comparative analgesic effects of naproxen sodium, aspirin, and placebo.
    Sevelius H, Segre E, Bursick K.
    J Clin Pharmacol; 1980 Jul 24; 20(7):480-5. PubMed ID: 7000856
    [Abstract] [Full Text] [Related]

  • 10. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V, Gréen K, Svanborg K.
    Acta Obstet Gynecol Scand Suppl; 1979 Jul 24; 87():51-6. PubMed ID: 111466
    [Abstract] [Full Text] [Related]

  • 11. Naproxen sodium, ibuprofen and a placebo in dysmenorrhea.
    Hanson FW.
    J Reprod Med; 1982 Jul 24; 27(7):423-7. PubMed ID: 6181256
    [Abstract] [Full Text] [Related]

  • 12. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
    Daniels SE, Torri S, Desjardins PJ.
    J Gen Intern Med; 2005 Jan 24; 20(1):62-7. PubMed ID: 15693930
    [Abstract] [Full Text] [Related]

  • 13. Naproxen sodium in dysmenorrhea secondary to endometriosis.
    Kauppila A, Rönnberg L.
    Obstet Gynecol; 1985 Mar 24; 65(3):379-83. PubMed ID: 3883265
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience.
    Jacobson J, Cavalli-Björkman K, Lundström V, Nilsson B, Norbeck M.
    Acta Obstet Gynecol Scand Suppl; 1979 Mar 24; 87():73-9. PubMed ID: 111467
    [Abstract] [Full Text] [Related]

  • 15. Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea.
    Mehlisch DR.
    Clin Ther; 1990 Mar 24; 12(5):398-409. PubMed ID: 2268862
    [Abstract] [Full Text] [Related]

  • 16. Plasma prostaglandin F 2-alpha levels in dysmenorrehic women.
    Shangold MM, Aksel S, Schomberg DW, Hammond CB.
    Fertil Steril; 1976 Oct 24; 27(10):1171-5. PubMed ID: 971774
    [Abstract] [Full Text] [Related]

  • 17. The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials.
    Henzl MR, Buttram V, Segre EJ, Bessler S.
    Am J Obstet Gynecol; 1977 Apr 15; 127(8):818-23. PubMed ID: 322491
    [Abstract] [Full Text] [Related]

  • 18. Naproxen, aspirin, and codeine in postpartum uterine pain.
    Bloomfield SS, Barden TP, Mitchell J.
    Clin Pharmacol Ther; 1977 Apr 15; 21(4):414-21. PubMed ID: 321177
    [Abstract] [Full Text] [Related]

  • 19. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
    Daniels SE, Talwalker S, Torri S, Snabes MC, Recker DP, Verburg KM.
    Obstet Gynecol; 2002 Aug 15; 100(2):350-8. PubMed ID: 12151162
    [Abstract] [Full Text] [Related]

  • 20. Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy.
    Henzl MR, Izu A.
    Acta Obstet Gynecol Scand Suppl; 1979 Aug 15; 87():105-17. PubMed ID: 380249
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.